O

Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives, all for scientific research purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Flourescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes

Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases, preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use; eukaryotic cells, eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture, and of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Fluorescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; sanitary preparations for medical purposes, namely, pharmaceutical agents for dental care